Granules India

Granules India Secures USFDA Tentative Approval for Generic ADHD Tablets; Eligible for 180-Day Exclusivity

Granules India Secures USFDA Tentative Approval for Generic ADHD Tablets; Eligible for 180-Day Exclusivity

By Axel Miller | 08 Jan 2026

Granules India arm gets USFDA tentative nod for generic ADHD tablets with 180-day exclusivity eligibility, expanding its $213M CNS portfolio.

Granules India gets USFDA nod

By Our Corporate Bureau | 24 May 2004

View details about the software product Informachine News Trackers

Latest articles

Report flags Southeast Asia AgriTech potential, cites India as reference model

 Report flags Southeast Asia AgriTech potential, cites India as reference model

India sugar output rises as faster crushing offsets early mill closures

 India sugar output rises as faster crushing offsets early mill closures

Ola Electric pricing claims remain unverified amid push for local battery production

 Ola Electric pricing claims remain unverified amid push for local battery production

India Post eyes logistics expansion as government pushes modernization agenda

 India Post eyes logistics expansion as government pushes modernization agenda

ISRO expands research access for Aditya-L1 as solar mission data draws scientific interest

 ISRO expands research access for Aditya-L1 as solar mission data draws scientific interest

Bharti Airtel expands subscriber base, strengthens global telecom presence

 Bharti Airtel expands subscriber base, strengthens global telecom presence

NASA targets Artemis II crewed Moon mission as next milestone in lunar program

 NASA targets Artemis II crewed Moon mission as next milestone in lunar program

Gas supply constraints weigh on Firozabad glass industry output

 Gas supply constraints weigh on Firozabad glass industry output

India keeps distance from Iranian oil as sanctions remain in place

 India keeps distance from Iranian oil as sanctions remain in place